Get started
Ardelyx, Inc.Ardelyx, Inc.Ardelyx, Inc.

Ardelyx, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

ARDX chart


Full chart

ARDX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.06 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.17 USD
Net income (FY)
‪−39.14 M‬ USD
Revenue (FY)
‪333.62 M‬ USD
Shares float
‪230.59 M‬
Beta (1Y)
0.41

Employees


Employees (FY)
395
Change (1Y)
+128 +47.94%
Revenue / Employee (1Y)
‪844.59 K‬ USD
Net income / Employee (1Y)
‪−99.08 K‬ USD

About Ardelyx, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Michael G. Raab
Website
ardelyx.com
Headquarters
Waltham
Founded
2007
FIGI
BBG001WH4DQ3
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ARDX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ARDX.

Frequently Asked Questions


The current price of ARDX is 4.58 USD — it has increased by 2.47% in the past 24 hours. Watch Ardelyx, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ardelyx, Inc. stocks are traded under the ticker ARDX.
ARDX stock has risen by 4.58% compared to the previous week, the month change is a −16.30% fall, over the last year Ardelyx, Inc. has showed a −35.29% decrease.
We've gathered analysts' opinions on Ardelyx, Inc. future price: according to them, ARDX price has a max estimate of 15.00 USD and a min estimate of 5.50 USD. Watch ARDX chart and read a more detailed Ardelyx, Inc. stock forecast: see what analysts think of Ardelyx, Inc. and suggest that you do with its stocks.
ARDX reached its all-time high on Dec 4, 2014 with the price of 35.48 USD, and its all-time low was 0.49 USD and was reached on Jun 16, 2022. View more price dynamics on ARDX chart.
See other stocks reaching their highest and lowest prices.
ARDX stock is 3.98% volatile and has beta coefficient of 0.41. Track Ardelyx, Inc. stock price on the chart and check out the list of the most volatile stocks — is Ardelyx, Inc. there?
Today Ardelyx, Inc. has the market capitalization of ‪1.09 B‬, it has decreased by −7.10% over the last week.
Yes, you can track Ardelyx, Inc. financials in yearly and quarterly reports right on TradingView.
Ardelyx, Inc. is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
ARDX earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0.00 USD resulting in a 386.14% surprise. The estimated earnings for the next quarter are −0.11 USD per share. See more details about Ardelyx, Inc. earnings.
Ardelyx, Inc. revenue for the last quarter amounts to ‪116.13 M‬ USD, despite the estimated figure of ‪109.94 M‬ USD. In the next quarter, revenue is expected to reach ‪78.20 M‬ USD.
ARDX net income for the last quarter is ‪4.64 M‬ USD, while the quarter before that showed ‪−809.00 K‬ USD of net income which accounts for 674.17% change. Track more Ardelyx, Inc. financial stats to get the full picture.
No, ARDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 395 employees. See our rating of the largest employees — is Ardelyx, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ardelyx, Inc. EBITDA is ‪−25.89 M‬ USD, and current EBITDA margin is −7.76%. See more stats in Ardelyx, Inc. financial statements.
Like other stocks, ARDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ardelyx, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ardelyx, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ardelyx, Inc. stock shows the sell signal. See more of Ardelyx, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.